Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PREHEVBRIO - Health Canada Drug Approval Details

Approvals/Health Canada/PREHEVBRIO

Authorized

STANDARD

PREHEVBRIO

VBI Vaccines Inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 4eefc080ceb645d1
Company: VBI Vaccines Inc
Type: Standard

Approval Details

Approval Id: 4eefc080ceb645d1
Drug Approval Canada Name: PREHEVBRIO
Product Name: PREHEVBRIO
Status: Approved
Status Date: 2022-12-06
Din: 02533286
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BC01 HEPATITIS B, PURIFIED ANTIGEN
Atc Name: j 07 bc 01
Aig Number: 0119570001
Company Name: VBI Vaccines Inc
Company Address: 310 Hunt Club Road, Ottawa, Ontario, Canada, K1V 1C1
Company Detail Path: /organization/vbi-vaccines-inc

Company Information

Pharmaceutical Company Name: VBI Vaccines Inc
Country Name: Canada
Province Name: Ontario
City Name: ottawa,ontario,country_ca
Address: 201-310 Hunt Club Rd

Active Ingredients

HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)

10 MCG / ML

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4eefc080ceb645d1

Type

Standard

Back to Health Canada Approvals